Table 3.
Cancer Stage | T1 |
T2 |
T3 |
||||||
---|---|---|---|---|---|---|---|---|---|
<16 n = 440 | ≥16 n = 81 | P | <16 n = 456 | ≥16 n = 62 | P | <16 n = 460 | ≥16 n = 55 | P | |
DCIS | 160 (36.4) | 19 (23.5) | 0.01 | 156 (34.2) | 21 (33.9) | 0.695 | 161 (35.0) | 15 (27.3) | 0.012 |
Stage I | 225 (51.1) | 43 (53.1) | 237 (52.0) | 30 (48.4) | 241 (52.4) | 25 (45.5) | |||
Stage IIA |
55 (12.5) |
19 (23.5) |
|
63 (13.8) |
11 (17.7) |
|
58 (12.6) |
15 (27.3) |
|
Group |
n = 869 |
n = 150 |
|
n = 886 |
n = 126 |
|
n = 895 |
n = 116 |
|
Patients | 440 (50.6) | 81 (54.0) | 0.446 | 456 (51.5) | 62 (49.2) | 0.635 | 460 (51.4) | 55 (47.4) | 0.419 |
Controls | 429 (49.4) | 69 (46.0) | 430 (48.5) | 64 (50.8) | 435 (48.6) | 61 (52.6) |